Our Edinburgh research centre is moving!

We are delighted to share that we are moving our Edinburgh base and headquarters to a newly refurbished research facility within Scottish Gas Murrayfield stadium.
Read more

Lecanemab is approved by MHRA in Great Britain, and restricted in NHS

Following today's announcements from the MHRA and NICE about a new drug, lecanemab - which approve its use in Great Britain, but block its adoption in NHS England - our CEO and Founder, Prof Craig Ritchie has responded.
Read more

Deputy First Minister announces Scottish Brain Sciences as anchor tenant in ONE BioHub Aberdeen

Our CEO, Prof Craig Ritchie, and Chair, Mark Cook, were delighted to meet with Deputy First Minister,Kate Forbes MSP, at our new base in ONE Biohub in Aberdeen.
Read more

New Alzheimer’s Vaccine Trial in Scotland

Scottish Brain Sciences is delighted to be the first clinical site open in the UK & Europe, to deliver a clinical trial of a new active immunotherapy (a vaccine) aimed at preventing or slowing the progression of Alzheimer's Disease.
Read more

Blood biomarkers can reveal Alzheimer disease progression, study finds

New blood tests for a protein linked with Alzheimer's Disease can identify those patients whose disease is progressing.
Read more
Two female researchers in a laboratory

Analysis Begins on Blood Samples for Markers of Alzheimer’s Disease

Researchers working in the Scottish Brain Sciences (SBS) Biomarker Laboratory have begun to analyse blood samples for markers of Alzheimer’s disease.
Read more

Research and publications